Distribution of vaccine/antivirals and the ‘least spread line’ in a stratified population
Open Access
- 14 October 2009
- journal article
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 7 (46), 755-764
- https://doi.org/10.1098/rsif.2009.0393
Abstract
We describe a prioritization scheme for an allocation of a sizeable quantity of vaccine or antivirals in a stratified population. The scheme builds on an optimal strategy for reducing the epidemic's initial growth rate in a stratified mass-action model. The strategy is tested on the EpiSims network describing interactions and influenza dynamics in the population of Utah, where the stratification we have chosen is by age (0–6, 7–13, 14–18, adults). No prior immunity information is available, thus everyone is assumed to be susceptible—this may be relevant, possibly with the exception of persons over 50, to the 2009 H1N1 influenza outbreak. We have found that the top priority in an allocation of a sizeable quantity of seasonal influenza vaccinations goes to young children (0–6), followed by teens (14–18), then children (7–13), with the adult share being quite low. These results, which rely on the structure of the EpiSims network, are compared with the current influenza vaccination coverage levels in the US population.Keywords
This publication has 15 references indexed in Scilit:
- Reproductive numbers, epidemic spread and control in a community of householdsMathematical Biosciences, 2009
- EpiFastPublished by Association for Computing Machinery (ACM) ,2009
- Vaccinating to Protect a Vulnerable SubpopulationPLoS Medicine, 2007
- Optimal harvesting and optimal vaccinationMathematical Biosciences, 2007
- Community Studies for Vaccinating Schoolchildren Against InfluenzaScience, 2006
- Epidemics in Heterogeneous Communities: Estimation of R0 and Secure Vaccination CoverageJournal of the Royal Statistical Society Series B: Statistical Methodology, 2001
- Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus VaccineThe Journal of Infectious Diseases, 2000
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenNew England Journal of Medicine, 1998
- The final size and severity of a generalised stochastic multitype epidemic modelAdvances in Applied Probability, 1993
- Epidemics in Heterogeneous Populations: Aspects of Optimal Vaccination PoliciesMathematical Medicine and Biology: A Journal of the IMA, 1989